https://alzheimereurope.newsweaver.com/Newsletter/ en-us 30 May 2025 04:17:32 CEST 30 May 2025 04:17:32 CEST https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true https://alzheimereurope.newsweaver.com/Newsletter/1onda99hbue?lang=en?rss=true Alzheimer Europe's May [ https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external ] 2025 newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share. [ https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external ] 30 May 2025 12:00:00 CEST ee9267cbc55d809f05601c3713646ea2 Feature Article <p style="text-align: justify;"><span style="font-size: 12px;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/19/ea8a85fca407401059a769.jpg" style="margin: 5px;" width="133" height="200" hspace="5" vspace="5" alt="Executive Director Jean Georges, June 2024">Alzheimer Europe's<strong> <a href="https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external" target="_blank" rel="noreferrer noopener"><strong>May </strong></a><span style="color: #004b96;"><strong><a href="https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external" target="_blank" rel="noreferrer noopener"><strong>2025 newsletter</strong></a></strong> </span></strong>brings you the latest news on developments in the dementia field, across Europe and beyond.</span></p> <p style="text-align: justify;"><span style="font-size: 12px;">Summaries of a few of our top stories appear below.</span></p> <p style="text-align: justify;"><span style="font-size: 12px;">Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond.</span></p> <p style="text-align: justify;"><span style="font-size: 12px;">We are always happy to receive feedback, or suggestions regarding news items to share.</span></p> <p style="text-align: justify;"> </p> <p class="centered-only" style="text-align: center;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/1r7vpvq49q3/external" target="_blank" rel="noreferrer noopener"><img align="middle" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/33/9a2b2c753c2ca4ee114ecc.jpg" style="margin: 0px;" width="200" height="48" hspace="0" vspace="0" alt=""></a></p> https://alzheimereurope.newsweaver.com/Newsletter/cnwrcvxxi7d?lang=en?rss=true Alzheimer Europe has signed a statement coordinated by the InRAD (International Registry for Alzheimer’s Disease and Other Dementias) Foundation, welcoming the approval of lecanemab in Europe and recognising the need to address questions surrounding its clinical use, including its safety and effectiveness in the real world. 30 May 2025 12:00:00 CEST 00ff5c6b4079ec938d19ad719fbce461 Other Articles <p style="text-align: justify;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/c6/587db14e6a531d6dbaab7d.png" style="margin: 5px;" width="150" height="151" hspace="5" vspace="5" alt="Inrad logo">Alzheimer Europe has signed a statement coordinated by the InRAD (International Registry for Alzheimer’s Disease and Other Dementias) Foundation, welcoming the approval of lecanemab in Europe and recognising the need to address questions surrounding its clinical use, including its safety and effectiveness in the real world.</p> https://www.alzheimer-europe.org/news/alzheimer-europe-joins-inrad-call-european-medicines-agency-alzheimers-registries https://alzheimereurope.newsweaver.com/Newsletter/86pyxv416tu?lang=en?rss=true A new Austrian Dementia Report 2025 provides a detailed analysis of healthcare provision, social support, as well as examining the living conditions of people with dementia and informal caregivers. The report was developed by Gesunheidt Österreich on behalf of the Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection. 30 May 2025 12:00:00 CEST a6fce6598b7a5a4793f27004b9d10cbe Other Articles <p style="text-align: justify;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/d6/583249e347dcb961a58b3e.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="Austrian Dementia report 2025 cover">A new Austrian Dementia Report 2025 provides a detailed analysis of healthcare provision, social support, as well as examining the living conditions of people with dementia and informal caregivers. The report was developed by Gesunheidt Österreich on behalf of the Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection.</p> https://www.alzheimer-europe.org/news/austria-publishes-dementia-report-2025 https://alzheimereurope.newsweaver.com/Newsletter/1spoxsu95fc?lang=en?rss=true On 23 May 2025, during the 78th World Health Assembly in Geneva (Switzerland), a six-year extension to the Global Action Plan on the Public Health Response to Dementia was adopted. This followed a recommendation adopted by the Executive Board of the World Health Organization (WHO) in February of this year. 30 May 2025 12:00:00 CEST 389730daee19f95c808983ebfed4d809 Other Articles <p style="text-align: justify;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/48/a80961dfa2770089c55387.png" style="margin: 5px;" width="150" height="157" hspace="5" vspace="5" alt="Global Action Plan cover">On 23 May 2025, during the 78th World Health Assembly in Geneva (Switzerland), a six-year extension to the Global Action Plan on the Public Health Response to Dementia was adopted. This followed a recommendation adopted by the Executive Board of the World Health Organization (WHO) in February of this year.</p> https://www.alzheimer-europe.org/news/world-health-assembly-approves-six-year-extension-global-action-plan-public-health-response https://alzheimereurope.newsweaver.com/Newsletter/16mzqrk8sxn?lang=en?rss=true Alzheimer Europe has newly launched a public opinion poll examining attitudes towards dementia research participation and data sharing. This poll is part of a broader initiative, which aims to understand motivators and barriers to dementia research participation and data sharing. We would appreciate your support! 30 May 2025 12:00:00 CEST 3770b0e0bb01d2dc3fb00014a3532eec Other Articles <p style="text-align: justify;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/f2/04cae38333da3ad66f7aba.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">Alzheimer Europe has newly launched a public opinion poll examining attitudes towards dementia research participation and data sharing. This poll is part of a broader initiative, which aims to understand motivators and barriers to dementia research participation and data sharing. We would appreciate your support!</p> https://www.alzheimer-europe.org/news/alzheimer-europe-launches-public-opinion-poll-examining-attitudes-towards-dementia-research